ICU Medical director awarded 1,475 RSUs

ICU Medical director Elisha W. Finney reported equity compensation activity involving Restricted Stock Units (RSUs).

Rhea-AI Filing Summary

ICU Medical director Elisha W. Finney reported equity compensation activity involving Restricted Stock Units (RSUs). On May 13, 2026, 1,254 RSUs were exercised into the same number of shares of common stock, increasing direct share ownership to 5,249 shares after the transaction. The filing also shows a new award of 1,475 RSUs, which carry no purchase or exercise price and are scheduled to vest on the first anniversary of the grant date or at the next annual stockholder meeting, whichever occurs first. These transactions reflect routine director compensation rather than open-market buying or selling.

Insider Trade Summary

1,254 shares exercised/converted

Exercise 3 txns

Insider FINNEY ELISHA W

Role Director

Type	Security	Shares	Price	Value
Exercise	Common Stock	1,254	$0.00	$0.00
Grant/Award	Common Stock	1,475	$0.00	$0.00
Exercise	Common Stock	1,254	$0.00	$0.00

Holdings After Transaction: Common Stock — 1,475 contracts (Direct); Common Stock — 5,249 shares (Direct)

Footnotes (3)

1. F1. These securities are Restricted Stock Units.
2. F2. There is neither a purchase price nor an exercise price for the Restricted Stock Units.
3. F3. These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

Key Figures

RSUs exercised into shares: 1,254 shares New RSU grant: 1,475 RSUs Shares held after transaction: 5,249 shares +2 more

5 metrics

RSUs exercised into shares 1,254 shares Restricted Stock Units converted to common stock on May 13, 2026

New RSU grant 1,475 RSUs Awarded to director Elisha W. Finney on May 13, 2026

Shares held after transaction 5,249 shares Direct common stock ownership following RSU conversion

RSU vesting condition Anniversary or next meeting RSUs vest on grant anniversary or next annual stockholder meeting

RSU purchase price $0.00 No purchase or exercise price for Restricted Stock Units

Key Terms

Restricted Stock Units, exercise or conversion of derivative security, grant, award, or other acquisition, annual stockholder meeting

4 terms

Restricted Stock Units financial

"These securities are Restricted Stock Units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

exercise or conversion of derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

annual stockholder meeting financial

"awards vest on the anniversary of the date of the grant or the following annual stockholder meeting"

An annual stockholder meeting is a yearly gathering where a company's owners (shareholders) receive updates on performance, vote on key issues like board members, executive pay and major corporate plans, and ask questions of management. Think of it as a company town hall where choices about oversight and direction are decided; outcomes can affect management accountability, corporate strategy and ultimately the value and risks of investors’ shares.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did ICU Medical (ICUI) director Elisha W. Finney report?

Elisha W. Finney reported routine equity compensation activity, including the exercise of 1,254 Restricted Stock Units into common shares and the grant of 1,475 new RSUs, all held directly as part of director compensation.

How many ICU Medical (ICUI) shares does Elisha W. Finney hold after these Form 4 transactions?

After these transactions, Elisha W. Finney directly holds 5,249 shares of ICU Medical common stock. This total reflects the conversion of 1,254 RSUs into shares reported as of May 13, 2026 in the insider filing.

What RSU grant did ICU Medical (ICUI) report for director Elisha W. Finney?

The filing shows a grant of 1,475 Restricted Stock Units to Elisha W. Finney. These RSUs have no purchase or exercise price and are scheduled to vest on the earlier of the grant anniversary or the next annual stockholder meeting.

Did Elisha W. Finney buy or sell ICU Medical (ICUI) shares on the open market?

The filing does not show any open-market buy or sell transactions. It reports an RSU conversion of 1,254 units into common stock and a grant of 1,475 RSUs, both characterized as equity compensation rather than market trades.

How do the new ICU Medical (ICUI) RSUs for Elisha W. Finney vest?

The newly granted Restricted Stock Units vest on the anniversary of the grant date or at the following annual stockholder meeting, whichever occurs first. Upon vesting, each RSU converts into one share of ICU Medical common stock.

What is notable about the pricing of Elisha W. Finney’s ICU Medical (ICUI) RSUs?

The RSUs carry no purchase or exercise price for Elisha W. Finney. The footnotes specify there is neither a purchase price nor an exercise price, consistent with standard director Restricted Stock Unit awards at many companies.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/13/2026 - 09:11 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FINNEY ELISHA W

(Last) (First) (Middle)

951 CALLE AMANECER

(Street)

SAN CLEMENTE CALIFORNIA 92673

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ICU MEDICAL INC/DE [ ICUI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	05/13/2026		M		1,254	A	$0(2)	5,249	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock(1)	$0(2)	05/13/2026		M			1,254	05/13/2026(3)	05/13/2026	Common Stock	1,254	$0	0	D
Common Stock(1)	$0(2)	05/13/2026		A		1,475		05/13/2027(3)	05/13/2027	Common Stock	1,475	$0	1,475	D

Explanation of Responses:

1. These securities are Restricted Stock Units.

2. There is neither a purchase price nor an exercise price for the Restricted Stock Units.

3. These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

	Paula Darbyshire, Attorney-in-fact For: Elisha W. Finney	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)